Chloramphenicol Succinic Acid

Summary

Chloramphenicol Succinic Acid (CHEMBL1201281) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 423.2 Da · C15H16Cl2N2O8

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201281
Name	Chloramphenicol Succinic Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	656580
Molecular formula	C15H16Cl2N2O8
Molecular weight	423.2
InChIKey	LIRCDOVJWUGTMW-ZWNOBZJWSA-N

SMILES: C1=CC(=CC=C1[C@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]

IUPAC name: 4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid

Also known as: Chloramphenicol succinate

Parent form; salt/anhydrous children: CHEMBL1200729

Patent coverage: 122 distinct patent families (209 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).